NCT01961609 2019-03-18
SIGNATURE
Novartis
Phase 3 Completed
Clinical Trials
4 trialsNCT02911857 2018-08-20
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Novartis
Phase 3 Completed
NCT01350804 2016-05-23
NURTURE 1
Novartis
Phase 3 Completed
NCT00584740 2015-03-31
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Novartis
Phase 2 Terminated